Morepen Laboratories

Morepen Laboratories R&D per Employee

The R&D Spending per Employee of Morepen Laboratories (MOREPENLAB.NS) as of Oct 23, 2026 is 15,445.12 INR. In the previous year, R&D Spending per Employee was 5,813.22 INR — a change of 165.69% (higher).

R&D per Employee

15,445.12INR

YoY

165.69%

Last updated:

R&D Spending per Employee of Morepen Laboratories is 2020 15,445.12 INR. R&D Spending per Employee of Morepen Laboratories was 2019 5,813.22 INR. It decreases by 165.69% higher compared to the previous year.

The Morepen Laboratories R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2014
2,304.43 INR
Jan 1, 2018
3,057.61 INR
Jan 1, 2019
5,813.22 INR
Jan 1, 2020
15,445.12 INR
The Morepen Laboratories R&D per Employee history
YEARR&D per EmployeeYoY
15,445.12INR+165.69%
5,813.22INR+90.12%
3,057.61INR+32.68%
2,304.43INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Morepen Laboratories Stock analysis

What does Morepen Laboratories do? Morepen Laboratories Ltd. generates revenue through the manufacturing and marketing of bulk drugs, pharmaceutical formulations, and home health products. The company produces active pharmaceutical ingredients (APIs) such as Apixaban, Edoxaban, Sitagliptin, and Rivaroxaban, which are sold to other pharmaceutical manufacturers. Its finished formulations, including Intebact Capsules, Intelicaps Lax, and Rythmix Kid Syrup, are marketed under its own brand for direct consumer sales. Home health products like the Dr. Morepen 49W Room Air Purifier and Dr. Morepen VP06 Breathe Free Vaporizer are sold directly to consumers through retail channels. The company's subsidiaries, Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited, support these product lines by handling specific manufacturing and distribution tasks. The primary customers for APIs are pharmaceutical companies seeking bulk ingredients for their own formulations. Finished formulations target healthcare consumers and pharmacies, while home health products are sold to households and medical facilities. The company's product segments are clearly divided: APIs for industrial clients, branded formulations for retail consumers, and home health devices for personal use. This segmentation allows Morepen to serve multiple market segments without overlapping product lines. Morepen's revenue streams are diversified across three main areas: API sales to pharmaceutical manufacturers, direct-to-consumer sales of branded formulations, and retail sales of home health products. The company's subsidiaries play a key role in supporting each segment, with Dr. Morepen Limited handling branded formulations, Morepen Devices Limited managing home health devices, and Total Care Limited likely supporting broader healthcare services. This structure ensures that each product line is efficiently managed and marketed to its respective target audience. Morepen Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Morepen Laboratories stock

R&D Spending per Employee of Morepen Laboratories is 15,445.12 INR in 2020.

R&D Spending per Employee of Morepen Laboratories changed from 5,813.22 INR to 15,445.12 INR, representing a 165.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Morepen Laboratories since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Morepen Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Morepen Laboratories

All Key Metrics — Morepen Laboratories